SEC 13F Intelligence

Assenagon Asset Management S.A. / BMRN

Assenagon Asset Management S.A.’s Biomarin Pharmaceutical Inc Position

Does Assenagon Asset Management S.A. own Biomarin Pharmaceutical Inc (BMRN)? Yes — 1.76M shares worth $101M (+0.13% of its 13F portfolio) as of Q2 2026, down from 1.92M shares the prior filed quarter.

Position Value
$101M
Q2 2026
Shares
1.76M
% of Portfolio
+0.13%
Quarters Held
23
currently held

Position History BMRN

Reported value by quarter
Q1 ’20: $1MQ1 ’20Q2 ’20: $3MQ3 ’20: $541,000Q3 ’21: $1MQ3 ’21Q4 ’21: $10MQ1 ’22: $4MQ2 ’22: $20MQ2 ’22Q3 ’22: $33MQ4 ’22: $73MQ1 ’23: $36MQ1 ’23Q2 ’23: $25MQ3 ’23: $9MQ4 ’23: $2MQ4 ’23Q1 ’24: $274,684Q2 ’24: $29MQ3 ’24: $8MQ3 ’24Q4 ’24: $40MQ1 ’25: $57MQ2 ’25: $57MQ2 ’25Q3 ’25: $19MQ4 ’25: $84MQ1 ’26: $108MQ1 ’26Q2 ’26: $101Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 20261.76M$101M+0.13%
Q1 20261.92M$108M+0.16%
Q4 20251.42M$84M+0.12%
Q3 2025344.1K$19M+0.03%
Q2 20251.04M$57M+0.08%
Q1 2025809.1K$57M+0.10%
Q4 2024611.7K$40M+0.06%
Q3 2024109.0K$8M+0.01%
Q2 2024352.5K$29M+0.06%
Q1 20243.1K$274,6840.00%
Q4 202317.0K$2M0.00%
Q3 2023103.1K$9M+0.03%
Q2 2023289.2K$25M+0.09%
Q1 2023368.7K$36M+0.13%
Q4 2022704.7K$73M+0.26%
Q3 2022391.2K$33M+0.13%
Q2 2022239.2K$20M+0.07%
Q1 202250.6K$4M+0.01%
Q4 2021118.7K$10M+0.03%
Q3 202114.6K$1M0.00%
Q3 20207.1K$541,0000.00%
Q2 202021.0K$3M+0.02%
Q1 202014.2K$1M+0.01%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Assenagon Asset Management S.A.’s full portfolio or all institutional holders of BMRN.